Targeting Viral and Cellular Cysteine Proteases for Treatment of New Variants of SARS-CoV-2

Targeting Viral and Cellular Cysteine Proteases for Treatment of New Variants of SARS-CoV-2

The continuous emergence of SARS-CoV-2 variants caused the persistence of the COVID-19 epidemic and challenged the effectiveness of the existing vaccines. The viral proteases are the most attractive targets for developing antiviral drugs. In this scenario, our study explores the use of HIV-1 proteas...

Full description

Bibliographic Details
Main Authors: Davide Gentile, Lucia Chiummiento, Alessandro Santarsiere, Maria Funicello, Paolo Lupattelli, Antonio Rescifina, Assunta Venuti, Anna Piperno, Maria Teresa Sciortino, Rosamaria Pennisi
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Viruses
Subjects:
SARS-CoV-2
cysteine protease
pseudovirus technology
Online Access:https://www.mdpi.com/1999-4915/16/3/338

Internet

https://www.mdpi.com/1999-4915/16/3/338

Similar Items